Inhibitory Traits of Dendrosome Curcumin (DNC) on Breast Cancer Compared to Curcumin Single Compound

  • Yasemin Khudiar Alghanimi
  • Abdolmajid GhasemianEmail author
Original Research



Vast therapeutic traits and very low toxicity of curcumin compound have made it and related formulations promising for treatment purposes. The aim of this study was the assessment of dendrosome curcumin (DNC) inhibitory effects on breast cancer therapy compared to single curcumin compound.


DNC was synthesized and MCF-7 cells were prepared. The cultured cells were treated with 20 μg/ml and 25 μg/ml of DNC. Real-time quantitative PCR (RT-qPCR) was performed to measure the expression of FOXCUT and MEG3 genes. Additionally, flow cytometry was applied to measure cell death rate and apoptosis.


The results outlined that DNC enhanced the MEG3 gene expression significantly higher than the control. Furthermore, DNC was associated with a significant decrease in the expression of FOXCUT gene as compared to the control. The application of DNC in the MCF7 cell line enhanced cell death and reduced necrosis.


The rate of apoptosis (programmed cell death) was enhanced, but necrosis was decreased in treated cancer cells compared to those treated with single curcumin. Accordingly, the DNC can be applied to hinder the growth and dissemination of cancer cells as a preferred approach to reduce the complications of other strategies such as chemotherapy and radiation therapy. Indeed, we concluded that DNC enhanced the expression of MEG3, a tumor suppressor, at 25 μm dose, but reduced the expression of the FOXCUT gene, possibly via the methylation of the gene. Thereby, DNC exerted a promising tumor inhibitory growth potential for the eradication of cancer cells.


Dendrosome curcumin Breast cancer MEG3 FOXCUT 



This study was supported by College of Education for Pure Sciences, Kerbala University, Biology Department, Iraq.

Compliance with Ethical Standards

Conflict of Interest

The authors declare that they have no conflict of interest.


  1. 1.
    Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.CrossRefGoogle Scholar
  2. 2.
    McGuire S. World cancer report 2014. Geneva: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015: Oxford University Press; 2016.Google Scholar
  3. 3.
    Carioli G, Malvezzi M, Rodriguez T, Bertuccio P, Negri E, La Vecchia C. Trends and predictions to 2020 in breast cancer mortality: Americas and Australasia. Breast. 2018;37:163–9.CrossRefGoogle Scholar
  4. 4.
    Tyanova S, Albrechtsen R, Kronqvist P, Cox J, Mann M, Geiger T. Proteomic maps of breast cancer subtypes. Nat Commun. 2016;7:10259.CrossRefPubMedCentralGoogle Scholar
  5. 5.
    Xu Y-z, Chen F-f, Zhang Y, Zhao Q-f, Guan X-l, Wang H-y, et al. The long noncoding RNA FOXCUT promotes proliferation and migration by targeting FOXC1 in nasopharyngeal carcinoma. Tumor Biol. 2017;39(6):1010428317706054.Google Scholar
  6. 6.
    Sreekutty J. Possible mechanism of action of albumin conjugated curcumin on lung cancer cells. Thiruvananthapuram: SCTIMST; 2017.Google Scholar
  7. 7.
    Yalameha B. Administration of herbal antioxidant to prevent and treatment of cancers. Ann Res Antioxid. 2018;3(1).Google Scholar
  8. 8.
    Nadaf SJ, Killedar SG. Curcumin nanocochleates: use of design of experiments, solid state characterization, in vitro apoptosis and cytotoxicity against breast cancer MCF-7 cells. J Drug Deliv Sci Technol. 2018;47:337–50.CrossRefGoogle Scholar
  9. 9.
    Khosropanah MH, Dinarvand A, Nezhadhosseini A, Haghighi A, Hashemi S, Nirouzad F, et al. Analysis of the antiproliferative effects of curcumin and nanocurcumin in MDA-MB231 as a breast cancer cell line. Iran J Pharm Res. 2016;15(1):231.PubMedCentralGoogle Scholar
  10. 10.
    Mukerjee A, Ranjan AP, Vishwanatha JK. Targeted nanocurcumin therapy using Annexin A2 antibody improves tumor accumulation and therapeutic efficacy against highly metastatic breast cancer. J Biomed Nanotechnol. 2016;12(7):1374–92.CrossRefGoogle Scholar
  11. 11.
    Arora R, Kuhad A, Kaur I, Chopra K. Curcumin loaded solid lipid nanoparticles ameliorate adjuvant-induced arthritis in rats. Eur J Pain. 2015;19(7):940–52.CrossRefGoogle Scholar
  12. 12.
    Brantl S. Regulatory mechanisms employed by cis-encoded antisense RNAs. Curr Opin Microbiol. 2007;10(2):102–9.CrossRefGoogle Scholar
  13. 13.
    Mattick JS, Rinn JL. Discovery and annotation of long noncoding RNAs. Nat Struct Mol Biol. 2015;22(1):5–7.CrossRefGoogle Scholar
  14. 14.
    Guo W, Dong Z, Shi Y, Liu S, Liang J, Guo Y, et al. Aberrant methylation-mediated downregulation of long noncoding RNA LOC100130476 correlates with malignant progression of esophageal squamous cell carcinoma. Dig Liver Dis. 2016;48(8):961–9.CrossRefGoogle Scholar
  15. 15.
    Dhamija S, Diederichs S. From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis. Int J Cancer. 2016;139(2):269–80.CrossRefGoogle Scholar
  16. 16.
    Jiang C, Li X, Zhao H, Liu H. Long non-coding RNAs: potential new biomarkers for predicting tumor invasion and metastasis. Mol Cancer. 2016;15(1):62.CrossRefPubMedCentralGoogle Scholar
  17. 17.
    Sannigrahi M, Sharma R, Panda N, Khullar M. Role of non-coding RNA s in head and neck squamous cell carcinoma: a narrative review. Oral Dis. 2018;24(8):1417–27.CrossRefGoogle Scholar
  18. 18.
    Saadipoor A, Razzaghdoust A, Simforoosh N, Mahdavi A, Bakhshandeh M, Moghadam M, et al. Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy. Phytother Res. 2018;33(2):370–378
  19. 19.
    Xie M, Fan D, Zhao Z, Li Z, Li G, Chen Y, et al. Nano-curcumin prepared via supercritical: improved anti-bacterial, anti-oxidant and anti-cancer efficacy. Int J Pharm. 2015;496(2):732–40.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.College of Education for Pure Sciences, Biology DepartmentKerbala UniversityKarbalaIraq
  2. 2.Department of Biology, Tehran Central BranchIslamic Azad UniversityTehranIran

Personalised recommendations